ClinicalTrials.gov
ClinicalTrials.gov Menu

Raltegravir And Darunavir Antiretroviral in Antiretroviral Naive Patients (RADAR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00677300
Recruitment Status : Completed
First Posted : May 14, 2008
Last Update Posted : September 8, 2014
Sponsor:
Collaborators:
Merck Sharp & Dohme Corp.
Tibotec Pharmaceutical Limited
Information provided by (Responsible Party):
Roger Bedimo, M.D., Dallas VA Medical Center